BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7596053)

  • 1. Bacteremia caused by the Bacteroides fragilis group in patients with hematologic diseases.
    Funada H; Matsuda T
    Jpn J Clin Oncol; 1995 Jun; 25(3):86-90. PubMed ID: 7596053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of and outcomes for Bacteroides fragilis bacteremia.
    Cheng CW; Lin HS; Ye JJ; Yang CC; Chiang PC; Wu TS; Lee MH
    J Microbiol Immunol Infect; 2009 Jun; 42(3):243-50. PubMed ID: 19812858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bloodstream infections due to anaerobic bacteria in cancer patients: epidemiology, etiology, risk factors, clinical presentation and outcome of anaerobic bacteremia.
    Spánik S; Trupl J; Kunová A; Pichna P; Helpianska L; Ilavská I; Kukucková E; Lacka J; Grausová S; Stopková K; Drgona L; Krcméry V
    Neoplasma; 1996; 43(4):235-8. PubMed ID: 8931747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bacteremia due to vancomycin-resistant enterococci in neutropenic cancer patients].
    Marron A; Carratalà J; Ayats J; Fernández de Sevilla A; Domínguez MA; Liñares J; Gudiol F
    Med Clin (Barc); 1998 Dec; 111(20):761-4. PubMed ID: 9922964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.
    Reuter S; Kern WV; Sigge A; Döhner H; Marre R; Kern P; von Baum H
    Clin Infect Dis; 2005 Apr; 40(8):1087-93. PubMed ID: 15791505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bacteremia caused by Stenotrophomonas maltophilia: a clinical-epidemiological study and resistance profile].
    Ubeda P; Salavert M; Giner S; Jarque I; López-Aldeguer J; Pérez-Bellés C; Gobernado M
    Rev Esp Quimioter; 1998 Sep; 11(3):205-15. PubMed ID: 9795306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteroides fragilis: a case study of bacteremia and septic arthritis.
    Martin T; Aziz H
    Clin Lab Sci; 2009; 22(3):131-5. PubMed ID: 19827405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical analysis of anaerobic septicemia in 26 patients with extensive burn].
    Huang X; Ma E; Gong L
    Zhonghua Wai Ke Za Zhi; 1995 Dec; 33(12):752-3. PubMed ID: 8762556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and microbiologic determinants of serious bloodstream infections in Egyptian pediatric cancer patients: a one-year study.
    El-Mahallawy H; Sidhom I; El-Din NH; Zamzam M; El-Lamie MM
    Int J Infect Dis; 2005 Jan; 9(1):43-51. PubMed ID: 15603994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and therapeutic outcome of patients with febrile neutropenia who present in shock: need for better strategies.
    Malik I; Hussain M; Yousuf H
    J Infect; 2001 Feb; 42(2):120-5. PubMed ID: 11531318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Staphylococcus aureus sepsis in hospitalized non neutropenic patients: retrospective clinical and microbiological analysis].
    Falcone M; Carfagna P; Cassone M; Pistella E; Pavoni G; Nofroni I; Serra P; Venditti M
    Ann Ital Med Int; 2002; 17(3):166-72. PubMed ID: 12402664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-acquired anaerobic bacteremia in adults: one-year experience in a medical center.
    Hung MN; Chen SY; Wang JL; Chang SC; Hsueh PR; Liao CH; Chen YC
    J Microbiol Immunol Infect; 2005 Dec; 38(6):436-43. PubMed ID: 16341345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies.
    Tsai MS; Kuo CY; Wang MC; Wu HC; Chien CC; Liu JW
    J Microbiol Immunol Infect; 2006 Apr; 39(2):150-4. PubMed ID: 16604248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
    Tamura K
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteremia caused by Capnocytophaga species in patients with neutropenia and cancer: results of a multicenter study.
    Martino R; Rámila E; Capdevila JA; Planes A; Rovira M; Ortega Md ; Plumé G; Gómez L; Sierra J
    Clin Infect Dis; 2001 Aug; 33(4):E20-2. PubMed ID: 11462207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents.
    Goldstein EJ
    Clin Infect Dis; 2002 Sep; 35(Suppl 1):S106-11. PubMed ID: 12173118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
    Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y
    Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fluoroquinolone prophylaxis utility during chemotherapy-induced severe neutropenia in patients with acute leukemia, with fluoroquinolone resistance high prevalence, in a reference hospital in Mexico City].
    Ugarte-Torres A; Villasis-Keever A; Hernández-Bribiesca ME; Crespo-Solis E; Ruiz-Palacios GM; Sifuentes-Osornio J; Ponce-De-León-Garduño A
    Rev Invest Clin; 2006; 58(6):547-54. PubMed ID: 17432285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenteral polymyxin B use in patients with multidrug-resistant gram-negative bacteremia and urinary tract infections: a retrospective case series.
    Pastewski AA; Caruso P; Parris AR; Dizon R; Kopec R; Sharma S; Mayer S; Ghitan M; Chapnick EK
    Ann Pharmacother; 2008 Sep; 42(9):1177-87. PubMed ID: 18664609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.